Screening and initial characterization of anticancer drugs are typically performed using monolayer cultures of tumor cells. It is well established that such monolayer cultures do not represent the characteristics of 3-dimensional solid tumors. The multicellular tumor spheroid model is of intermediate complexity between in vivo tumors and in vitro monolayer cultures and would be more suitable for drug screening. The authors describe a procedure in which multicellular spheroids are used to screen for compounds that induce tumor cell apoptosis. Multicellular spheroids were generated in 96-well plates, and apoptosis was determined using the M30-Apoptosense ® enzyme-linked immunosorbent assay method. A Z′ factor of approximately 0.5 was observed for HCT116 colon carcinoma spheroids using staurosporine to induce apoptosis. This procedure is attractive for secondary screening of hits from larger cell-based screens. (Journal of Biomolecular Screening 2008:1-8)
Sutherland RM , Eddy HA, Bareham B., Reich K., Vanantwerp D.: Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys1979 ;5:1225-1230.
2.
Tunggal JK, Cowan DS, Shaikh H., Tannock IF: Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res1999;5:1583-1586.
3.
Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ: Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res2002;8:878-884.
4.
Sutherland RM , Durand RE: Radiation response of multicell spheroids— an in vitro tumour model. Curr TopRadiat Res Q1976;11:87-139.
5.
Mueller-Klieser W.: Multicellular spheroids: a review on cellular aggregates in cancer research. J Cancer Res Clin Oncol1987;113:101-122.
Sutherland RM : Cell and environment interactions in tumor microregions: the multicell spheroid model. Science1988;240:177-184.
8.
Ivascu A., Kubbies M.: Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen2006 ; 11:922-932.
9.
Nederman T.: Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. Cancer Res1984;44: 254-258.
10.
Olive PL, Banath JP, Evans HH: Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging . Br J Cancer1993;67: 522-530.
11.
Kobayashi H. , Man S., Graham CH, Kapitain SJ, Teicher BA, Kerbel RS: Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci USA1993;90:3294-3298.
12.
Francia G., Man S., Teicher B., Grasso L., Kerbel RS: Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Mol Cell Biol2004; 24:6837-6849.
13.
Kelm JM, Timmins NE, Brown CJ, Fussenegger M., Nielsen LK: Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng2003;83:173-180.
14.
Timmins NE, Dietmair S., Nielsen LK: Hanging-drop multicellular spheroids as a model of tumour angiogenesis . Angiogenesis2004;7: 97-103.
15.
Hägg M. , Biven K., Ueno T., Rydlander L., Björklund P., Wiman KG, et al: A novel high-through-put assay for screening of pro-apoptotic drugs. Invest New Drugs2002;20:253-259.
16.
Cummings J. , Ward TH, LaCasse E., Lefebvre C., St-Jean M., Durkin J., et al: Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer2005;92:532-538.
17.
Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen1999;4:67-73.
18.
Wijffels KI , Kaanders JH, Rijken PF, Bussink J., van den Hoogen FJ, Marres HA, et al: Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas . Br J Cancer2000;83:674-683.
19.
Mueller-Klieser WF, Sutherland RM: Oxygen tensions in multicell spheroids of two cell lines. Br J Cancer1982;45:256-264.
20.
Santini MT, Rainaldi G.: Three-dimensional spheroid model in tumor biology. Pathobiology1999;67:148-157.
21.
Fisher JL, Schmitt JF, Howard ML, Mackie PS, Choong PF, Risbridger GP: An in vivo model of prostate carcinoma growth and invasion in bone . Cell Tissue Res2002;307:337-345.
22.
Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown JP, et al: Requirement for p53 and p21 to sustain G2 arrest after DNA damage . Science1998;282:1497-1501.
23.
Zhang L., Yu J., Park BH, Kinzler KW, Vogelstein B.: Role of BAX in the apoptotic response to anticancer agents. Science2000;290:989-992.
24.
Yu J., Wang Z., Kinzler KW, Vogelstein B., Zhang L.: PUMA mediates the apoptotic response to p53 in colorectal cancer cells . Proc Natl Acad Sci USA2003;100:1931-1936.
25.
Poland J., Sinha P., Siegert A., Schnolzer M., Korf U., Hauptmann S.: Comparison of protein expression profiles between monolayer and spheroid cell culture of HT-29 cells revealed fragmentation of CK18 in three-dimensional cell culture. Electrophoresis2002;23:1174-1184.
26.
Schutte B., Henfling M., Kolgen W., Bouman M., Meex S., Leers MP, et al: Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res2004;297:11-26.
27.
Hägg Olofsson M., Ueno T., Pan Y., Xu R., Cai F., van der Kuip H., et al: Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res2007; 13:3198-3206.
28.
Hägg M., Berndtsson M., Mandic A., Zhou R., Shoshan MC, Linder S.: Induction of endoplasmic reticulum stress by ellipticine plant alkaloids . Mol Cancer Ther2004;3:489-497.
29.
Erdal H., Berndtsson M., Castro J., Brunk U., Shoshan MC, Linder S.: Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA2005;102:192-197.
